nCPAP for Infants Part 2: Overview of nCPAP Delivery Systems webcast
Respiratory distress syndrome (RDS) remains a common diagnosis for premature infants. For those premature infants requiring additional respiratory support, neonatal continuous positive airway pressure (nCPAP) has been shown to be an effective method for improving functional residual capacity (FRC) and oxygenation.1,2 nCPAP is a recognized treatment in helping prevent alveolar collapse and decreasing intrapulmonary shunt that employs various types of nCPAP devices and interfaces.1,2,3 When compared to conventional ventilation, nCPAP may reduce incidence of ventilator-induced injury and chronic lung disease in infants—demonstrated by favorable small airway function as well as decreased mortality.4,5
This webcast is part 2 of a series on nCPAP that discusses methods of nCPAP with a high flow nasal cannula, bubble nCPAP, ventilator-generated nCPAP and flow driver nCPAP.
This program is approved for 1 hour of CRCE credit.
If viewing as a group, all participants wishing to obtain CRCE credit must pre-register. In addition, you can obtain group viewing instructions, a roster and evaluation forms from your local sales representative.
This webcast is approved by the American Association for Respiratory Care (AARC).
Already registered? View the webcast.
Understand methods of nCPAP with a high flow nasal cannula, bubble nCPAP, ventilator-generated nCPAP and flow driver nCPAP
Discuss the advantages and disadvantages of each nCPAP device
Obtain knowledge on peer-reviewed studies